BioXcel Therapeutics's Stock Price And Volume Action
BioXcel Therapeutics BTAI is currently down 12.05% to a price of $38.97. The stock's current volume for the day is 66.84 thousand, which is approximately 13.37% of its previous 30-day average volume of 499.89 thousand.
Why It's Moving
Benzinga Pro's real-time breaking news service shows some insight into what is affecting shares: BioXcel Therapeutics shares are trading lower after the company announced topline results from its Phase 1b/2 proof-of-concept RELEASE study of BXCL501.
Insights On Recent Price Action
The 50-day moving average price of BioXcel Therapeutics's stock was $50.16 when this article was published. The stock reached a high of $71.5 and a low of $16.0 in the past 52 weeks.
If you're looking for timely and concise explanations of why a stock is moving, check out Benzinga Pro. Subscribers get ‘Why Is It Moving' alerts as soon as our research team identifies the cause of the price action in a stock. Click here to learn more.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.